Bioserenity

Bioserenity

BioSerenity
TypePrivately held company
Industryresearch and development in biotechnology Edit this on Wikidata
FoundedJanuary 29, 2014 (2014-01-29)
FounderPierre-Yves Frouin
Headquarters
Paris
,
France
Area served
US, France, China
ProductsNeuronaute, Cardionaute, Cardioskin[1]
ServicesNeurophy, Cardiophy, Somnophy[2]
Number of employees
400 (2019)
Websitewww.bioserenity.com

BioSerenity is a medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases[3] such as epilepsy.[4] The medical devices are composed of medical sensors, smart clothing or consumables,[5] a smartphone app for Patient Reported Outcome, and a web platform to perform data analysis through Medical Artificial Intelligence[6][7] for detection of digital biomarkers.[8] The company initially focused on Neurology,[9] a domain in which it reported contributing to the diagnosis of 30 000 patients per year.[10] It now also operates in Sleep Disorders and Cardiology.[11] BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.[12]

Company history

BioSerenity was founded in 2014, by Pierre-Yves Frouin. The company was initially hosted at the ICM Institute (Institute du Cerveau et de la Moëlle épinière),[13][14] in Paris, France.

Fund Raising

Receivership and acquisition by private equity group

On 21 July 2023, BioSerenity SAS entered the French equivalent of receivership. The company was acquired by private equity group Jolt Capital and recapitalized up to €30M[18][19][20] Operations continued under the new ownership.

Acquisitions

In 2019, BioSerenity announced the acquisition of the American Company SleepMed[21] and Novasom[22]

Development

In 2019, was working with over 200 Hospitals.

In 2020, BioSerenity was one of the five French manufacturers (Savoy, BB Distrib, Celluloses de Brocéliande, Chargeurs) working on the production of sanitary equipment including FFP2 masks at request of the French government.[23]

In 2021, the Neuronaute was used by approximately 30,000 patients per year.[24]

In 2023, the company launched the Icecap, a single use EEG solution[25][26] and its A.I. model for Sleep Disorders with teams from Stanford University.[27][28][29]

In 2025, the company was performing more than 45,000 EEGs (electroencephalograms), 8,000 PSGs (polysomnographies), and 5,000 ECGs (electrocardiograms) each year.[30] The company launched a new EEG A.I. model[31] and signed an agreement to distribute its solutions in the USA through Stratus.[32]

In November 2025, Emmanuel Mougeotte, former CEO of CompuGroup Medical France, became CEO of the company [33] and in January 2026, Pierre-Yves Frouin, founder of BioSerenity concluded his tenure and exited the company.[34]

In March 2026, the company opened an affiliate in Germany.[35]

Awards

  • BioSerenity is one of the Disrupt 100[36]
  • BioSerenity joined the Next40[37]
  • BioSerenity was selected by Microsoft and AstraZeneca in their initiative AI Factory for Health[38]
  • BioSerenity accelerated at Stanford's University StartX program[39]

References

  1. ^ Fouassier, David (2020). "Assessment of signal quality measured with a smart 12-lead ECG acquisition T-shirt". Annals of Noninvasive Electrocardiology. 25 (1) e12682. Wiley. doi:10.1111/anec.12682. PMC 7050501. PMID 31339208.(citing PMID 31339208)
  2. ^ Cairns, Alyssa (February 2019). "Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases". Neurobiology of Sleep and Circadian Rhythms. 6. Elsevier: 62–69. doi:10.1016/j.nbscr.2019.02.001. PMC 6586604. PMID 31236521.(citing PMID 31236521)
  3. ^ "La HealthTech, la mine d'or méconnue de la French Tech". latribune.fr (in French). February 12, 2020. Retrieved September 10, 2021.
  4. ^ "NHS could soon use smart outfit to diagnose epilepsy". www.newscientist.com. June 1, 2016. Retrieved September 10, 2021.
  5. ^ "Textiles connectés, où quand les vêtements scrutent les mouvements". Le Temps (in French). January 29, 2016. Retrieved September 10, 2021.
  6. ^ Le Van Quyen, Michel (2018). "An Ensemble Learning Approach to Detect Epileptic Seizures from Long Intracranial EEG Recordings". 2018 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP). Calgary: IEEE. pp. 856–860. doi:10.1109/ICASSP.2018.8461489. ISBN 978-1-5386-4658-8. S2CID 52283583.
  7. ^ "Intelligence artificielle : la course aux bases de données". Le Monde.fr. May 8, 2017.
  8. ^ "BioSerenity : l'intelligence artificielle et la data au service du patient". Les Echos (in French). September 20, 2019. Retrieved September 10, 2021.
  9. ^ "Wearable technology: Clothing designed to save your life". BBC News. August 25, 2014.
  10. ^ "These Sensor-Studded Smart Clothes Just Might Save Your Life". www.wsj.com. September 7, 2021. Retrieved September 10, 2021.
  11. ^ "'Cardioskin' T-shirt tracks heart rhythm around the clock". cardiovascularbusiness.com. September 13, 2018.
  12. ^ "Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity". businessinsider.com. June 19, 2019. Archived from the original on March 2, 2020. Retrieved September 10, 2021.
  13. ^ "BioSerenity". www.icm-institute.org/.
  14. ^ "Un tee-shirt qui diagnostique l'épilepsie". Le Monde.fr. September 30, 2014.
  15. ^ "KURMA ANNOUNCES THE FIRST INVESTMENT OF THEIR NEWLY LAUNCHED DIAGNOSTICS FUNDS IN THE START UP COMPANY BIOSERENITY" (PDF). www.kurmapartners.com. June 8, 2015. Retrieved September 10, 2021.
  16. ^ "BioSerenity, champion français de la e-santé, lève 15 millions d'Euros" (PDF). lyonbiopole.com (in French). September 20, 2017. Archived from the original (PDF) on June 16, 2021. Retrieved September 10, 2021.
  17. ^ "BioSerenity, champion MedTech spécialisé dans les solutions de diagnostic et de télé-expertise, lève 65 millions d'euros pour étendre son activité aux Etats-Unis et approfondir ses solutions IoT et d'Intelligence Artificielle" (PDF). www.lbofrance.com (in French). June 18, 2019. Archived from the original (PDF) on November 4, 2019. Retrieved September 10, 2021.
  18. ^ "BioSerenity : l'encéphalogramme redémarre". Les Petites Affiches Matot Braine (in French). August 11, 2025. Retrieved June 8, 2026.
  19. ^ "La medtech française BioSerenity sauvée de la liquidation par Jolt Capital pour 24 millions d'euros". L'Usine Digitale (in French). November 14, 2023.
  20. ^ "BIOSERENITY (799995782) - Tribunal de commerce de Paris, jugement P202302177". societe.com. Retrieved May 7, 2026.
  21. ^ Loye, Deborah (September 23, 2019). "BioSerenity rachète l'américain SleepMed". Les Echos Executives (in French). Retrieved September 10, 2021.
  22. ^ Christie, Jim (September 24, 2019). "IN BRIEF: BioSerenity to buy NovaSom out of bankruptcy". Reuters. Retrieved January 22, 2026.
  23. ^ "Les usines de l'Hexagone en ordre de bataille pour les protections sanitaires". LEFIGARO (in French). July 28, 2020. Retrieved June 30, 2022.
  24. ^ Ledoux, Aurélie (2009). "Vidéos en ligne : la preuve par l'image ?". Esprit. Mars/avril (3): 95–106. doi:10.3917/espri.0903.0095. ISSN 0014-0759.
  25. ^ "About us". groupe bioserenity. Retrieved January 22, 2026.
  26. ^ "ICECap". BioSerenity. Retrieved January 22, 2026.
  27. ^ "Research". BioSerenity. Retrieved January 22, 2026.
  28. ^ Rahmouni, Mohamed; Bussalb, Aurore; Elbaz, Maxime; Jubien, Guillaume; Gimenez, Ulysse (March 1, 2024). "Algorithmes de détection de micro-éveils de haute performance avec un modèle de deep learning". Médecine du Sommeil. Le congrès du sommeil. 21 (1): 8. doi:10.1016/j.msom.2023.12.014. ISSN 1769-4493.
  29. ^ Hanif, Umaer; Gimenez, Ulysse; Cairns, Alyssa; Lewin, Daniel; Ashraf, Nisar; Mignot, Emmanuel (July 2023). "Automatic Detection of Chronic Insomnia from Polysomnographic and Clinical Variables Using Machine Learning". 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). Vol. 2023. pp. 1–5. doi:10.1109/EMBC40787.2023.10340587. ISBN 979-8-3503-2447-1. ISSN 2694-0604. PMID 38083711.
  30. ^ "Emmanuel Mougeotte is BIOSerenity's new CEO". Jolt Capital. Retrieved January 22, 2026.
  31. ^ Bettinardi, Ruggero G.; Rahmouni, Mohamed; Gimenez, Ulysse (March 13, 2025), BioSerenity-E1: a self-supervised EEG model for medical applications, arXiv:2503.10362
  32. ^ "Stratus Partners with BioSerenity to Become U.S. Distributor of IceCap® Product Line". stratusneuro.com. Retrieved January 22, 2026.
  33. ^ "Emmanuel Mougeotte is BIOSerenity's new CEO". Jolt Capital. Retrieved January 22, 2026.
  34. ^ "Former CEO concludes his tenure after 11 years". Jolt Capital. Retrieved January 22, 2026.
  35. ^ "Unternehmensregister - Die zentrale Plattform zu Unternehmensdaten". www.unternehmensregister.de. Retrieved April 24, 2026.
  36. ^ "BioSerenity". disrupt100.com. Archived from the original on February 27, 2020. Retrieved September 10, 2021.
  37. ^ "BioSerenity". Next40.org (in French). November 25, 2014. Retrieved September 10, 2021.
  38. ^ "These 6 startups were selected to join Microsoft and AstraZeneca's AI Factory for Health". www.bioportfolio.com. March 12, 2020.
  39. ^ "Companies". www.startx.com.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.